L2MTech GmbH incorporatedin 2017 & is a multinational medical device company headquartered at Bonn, Germany. We design, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments globally.
L2MTech is a growing Life Sciences Corporation specializing in Research, Development, Manufacture of Interventional Cardiovascular and Endovascular products. The Organizationhas implemented Quality Management system to EN ISO 13485:2016 standard and regulatory meeting to 93/42/EEC as amended by 2007/47/EC.

The organization has identified market potential across geographies and planned to meet the requirements of National & International customers / end users. The company will provide interventional physicians with innovative vascular devices including coronary stents made in Europe for the world.
Our Core mission is to build a product portfolio focused on minimally invasive treatment for patients with cardiovascular, endovascular and vascular artery disease

Coronary Products
Peripheral Products
Coating Technology
Why use BTHC coating....
Safe and proven track record-both CE/FDA approved
Established excipient with paclitaxel drug and assist in drug uptake
Proven combination –As seen in comparative study by major competitors (PEPPER Trial)
Strengths
Experienced Sales & Marketing team with more than 20 years in the industry
Existing distributor relationship
Team has excellent relation with KOL’s (Key Opinion Leaders)
Focused Approach/Quick Decision Making
Covering both the Cardiovascular and Endovascular market
Conclusion & Discussions
L2M is a growing Life Sciences Corporation specializing in R&D and Manufacturing of Interventional Cardiovascular and Endovascular products. We are a multinational medical device company headquartered out of Bonn, Germany. We design, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in various countries across the globe.
The company will provide interventional physicians with innovative vascular devices including coronary stents made in Europe for the world.